US 6916961
β2-adrenergic receptor agonists
expired A61KA61K31/137A61K31/167
Quick answer
US patent 6916961 (β2-adrenergic receptor agonists) held by Theravance, Inc. expires Mon Jul 07 2025 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- Theravance, Inc.
- Grant date
- Tue Jul 12 2005 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 07 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K31/137, A61K31/167, A61K31/403, A61K31/404